APO Research, Inc.

APO RESEARCH · REPORT

Laboratory-Developed Testing Service

Selected research

Market Outlook & Growth Opportunities

Global Laboratory-Developed Testing Service Market Outlook and Growth Opportunities 2026

Market perspective

The global Laboratory-Developed Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Laboratory-Developed Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Laboratory-Developed Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Laboratory-Developed Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Laboratory-Developed Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Laboratory-Developed Testing Service market include Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina, Qiagen, Eurofins, Guardant Health and Adaptive Biotechnologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Laboratory-Developed Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Laboratory-Developed Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Laboratory-Developed Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Laboratory-Developed Testing Service market.

Laboratory-Developed Testing Service Segment by Company

Quest Diagnostics

Thermo Fisher

Waters Corporation

Roche

Illumina

Qiagen

Eurofins

Guardant Health

Adaptive Biotechnologies

Biodesix

Berry Oncology

Genetron Health

SRL

BML

Laboratory-Developed Testing Service Segment by Type

Rapid Testing (24–48 Hours)

Standard Testing (3–7 Days)

In-depth Analysis (7–14+ Days)

Laboratory-Developed Testing Service Segment by Application

Hospitals Laboratory

Clinical Research Organizations

Academic Institutes

Specialty Diagnostic Centers

Others

Laboratory-Developed Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Laboratory-Developed Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Laboratory-Developed Testing Service key companies, revenue, market share, and recent developments.

3. To split the Laboratory-Developed Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Laboratory-Developed Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Laboratory-Developed Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Laboratory-Developed Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-Developed Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laboratory-Developed Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-Developed Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laboratory-Developed Testing Service industry.

Chapter 3: Detailed analysis of Laboratory-Developed Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Laboratory-Developed Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Laboratory-Developed Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Laboratory-Developed Testing Service Industry Trends Table 2. Laboratory-Developed Testing Service Industry Drivers Table 3. Laboratory-Developed Testing Service Industry Opportunities and Challenges Table 4. Laboratory-Developed Testing Service Industry Restraints Table 5. Global Laboratory-Developed Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Laboratory-Developed Testing Service Revenue Share by Company (2021-2026) Table 7. Global Laboratory-Developed Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Laboratory-Developed Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global Laboratory-Developed Testing Service Company, Product Type & Application Table 10. Global Laboratory-Developed Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Laboratory-Developed Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Rapid Testing (24–48 Hours) Table 15. Significant Companies of Standard Testing (3–7 Days) Table 16. Significant Companies of In-depth Analysis (7–14+ Days) Table 17. Global Laboratory-Developed Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Laboratory-Developed Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Laboratory-Developed Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Laboratory-Developed Testing Service Sales Value Share by Type (2021-2026) Table 21. Global Laboratory-Developed Testing Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Laboratory Table 23. Significant Companies of Clinical Research Organizations Table 24. Significant Companies of Academic Institutes Table 25. Significant Companies of Specialty Diagnostic Centers Table 26. Significant Companies of Others Table 27. Global Laboratory-Developed Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Laboratory-Developed Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Laboratory-Developed Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Laboratory-Developed Testing Service Sales Value Share by Application (2021-2026) Table 31. Global Laboratory-Developed Testing Service Sales Value Share by Application (2027-2032) Table 32. Global Laboratory-Developed Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Laboratory-Developed Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Laboratory-Developed Testing Service Sales Value Share by Region (2021-2026) Table 35. Global Laboratory-Developed Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Laboratory-Developed Testing Service Sales Value Share by Region (2027-2032) Table 37. Global Laboratory-Developed Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Laboratory-Developed Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Laboratory-Developed Testing Service Sales Value Market Share by Country (2021-2026) Table 40. Global Laboratory-Developed Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Laboratory-Developed Testing Service Sales Value Market Share by Country (2027-2032) Table 42. Quest Diagnostics Company Information Table 43. Quest Diagnostics Business Overview Table 44. Quest Diagnostics Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Quest Diagnostics Laboratory-Developed Testing Service Product Portfolio Table 46. Quest Diagnostics Recent Development Table 47. Thermo Fisher Company Information Table 48. Thermo Fisher Business Overview Table 49. Thermo Fisher Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Thermo Fisher Laboratory-Developed Testing Service Product Portfolio Table 51. Thermo Fisher Recent Development Table 52. Waters Corporation Company Information Table 53. Waters Corporation Business Overview Table 54. Waters Corporation Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Waters Corporation Laboratory-Developed Testing Service Product Portfolio Table 56. Waters Corporation Recent Development Table 57. Roche Company Information Table 58. Roche Business Overview Table 59. Roche Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Roche Laboratory-Developed Testing Service Product Portfolio Table 61. Roche Recent Development Table 62. Illumina Company Information Table 63. Illumina Business Overview Table 64. Illumina Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Illumina Laboratory-Developed Testing Service Product Portfolio Table 66. Illumina Recent Development Table 67. Qiagen Company Information Table 68. Qiagen Business Overview Table 69. Qiagen Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Qiagen Laboratory-Developed Testing Service Product Portfolio Table 71. Qiagen Recent Development Table 72. Eurofins Company Information Table 73. Eurofins Business Overview Table 74. Eurofins Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Eurofins Laboratory-Developed Testing Service Product Portfolio Table 76. Eurofins Recent Development Table 77. Guardant Health Company Information Table 78. Guardant Health Business Overview Table 79. Guardant Health Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Guardant Health Laboratory-Developed Testing Service Product Portfolio Table 81. Guardant Health Recent Development Table 82. Adaptive Biotechnologies Company Information Table 83. Adaptive Biotechnologies Business Overview Table 84. Adaptive Biotechnologies Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Adaptive Biotechnologies Laboratory-Developed Testing Service Product Portfolio Table 86. Adaptive Biotechnologies Recent Development Table 87. Biodesix Company Information Table 88. Biodesix Business Overview Table 89. Biodesix Laboratory-Developed Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Biodesix Laboratory-Developed Testing Service Product Portfolio Table 91. Biodesix Recent Development Table 92. Berry Oncology Company Information Table 93. Berry Oncology Business Overview Table 94. Berry Oncology Laboratory-Developed Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Berry Oncology Laboratory-Developed Testing Service Product Portfolio Table 96. Berry Oncology Recent Development Table 97. Genetron Health Company Information Table 98. Genetron Health Business Overview Table 99. Genetron Health Laboratory-Developed Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Genetron Health Laboratory-Developed Testing Service Product Portfolio Table 101. Genetron Health Recent Development Table 102. SRL Company Information Table 103. SRL Business Overview Table 104. SRL Laboratory-Developed Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. SRL Laboratory-Developed Testing Service Product Portfolio Table 106. SRL Recent Development Table 107. BML Company Information Table 108. BML Business Overview Table 109. BML Laboratory-Developed Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. BML Laboratory-Developed Testing Service Product Portfolio Table 111. BML Recent Development Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Laboratory-Developed Testing Service Product Image Figure 2. Global Laboratory-Developed Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laboratory-Developed Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Laboratory-Developed Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Rapid Testing (24–48 Hours) Image Figure 8. Standard Testing (3–7 Days) Image Figure 9. In-depth Analysis (7–14+ Days) Image Figure 10. Global Laboratory-Developed Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Laboratory-Developed Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Laboratory-Developed Testing Service Sales Value Share by Type (2021-2032) Figure 13. Hospitals Laboratory Image Figure 14. Clinical Research Organizations Image Figure 15. Academic Institutes Image Figure 16. Specialty Diagnostic Centers Image Figure 17. Others Image Figure 18. Global Laboratory-Developed Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Laboratory-Developed Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Laboratory-Developed Testing Service Sales Value Share by Application (2021-2032) Figure 21. Global Laboratory-Developed Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Laboratory-Developed Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Laboratory-Developed Testing Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Laboratory-Developed Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Laboratory-Developed Testing Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Laboratory-Developed Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Laboratory-Developed Testing Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Laboratory-Developed Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Laboratory-Developed Testing Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Laboratory-Developed Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Laboratory-Developed Testing Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Laboratory-Developed Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Rapid Testing (24–48 Hours)
  • Standard Testing (3–7 Days)
  • In-depth Analysis (7–14+ Days)
Applications
  • Hospitals Laboratory
  • Clinical Research Organizations
  • Academic Institutes
  • Specialty Diagnostic Centers
  • Others
Companies covered
  • Quest Diagnostics
  • Thermo Fisher
  • Waters Corporation
  • Roche
  • Illumina
  • Qiagen
  • Eurofins
  • Guardant Health
  • Adaptive Biotechnologies
  • Biodesix
  • Berry Oncology
  • Genetron Health
  • SRL
  • BML

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Laboratory-Developed Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Laboratory-Developed Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Laboratory-Developed Testing Service Market Dynamics
  1. 2.1 Laboratory-Developed Testing Service Industry Trends
  2. 2.2 Laboratory-Developed Testing Service Industry Drivers
  3. 2.3 Laboratory-Developed Testing Service Industry Opportunities and Challenges
  4. 2.4 Laboratory-Developed Testing Service Industry Restraints
3 Laboratory-Developed Testing Service Market by Company
  1. 3.1 Global Laboratory-Developed Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global Laboratory-Developed Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global Laboratory-Developed Testing Service Company Ranking (2024-2026)
  4. 3.4 Global Laboratory-Developed Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Laboratory-Developed Testing Service Company Product Type and Application
  6. 3.6 Global Laboratory-Developed Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Laboratory-Developed Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Laboratory-Developed Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Laboratory-Developed Testing Service Market by Type
  1. 4.1 Laboratory-Developed Testing Service Type Introduction
  2. 4.1.1 Rapid Testing (24–48 Hours)
  3. 4.1.2 Standard Testing (3–7 Days)
  4. 4.1.3 In-depth Analysis (7–14+ Days)
  5. 4.2 Global Laboratory-Developed Testing Service Sales Value by Type
  6. 4.2.1 Global Laboratory-Developed Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Laboratory-Developed Testing Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Laboratory-Developed Testing Service Sales Value Share by Type (2021-2032)
5 Laboratory-Developed Testing Service Market by Application
  1. 5.1 Laboratory-Developed Testing Service Application Introduction
  2. 5.1.1 Hospitals Laboratory
  3. 5.1.2 Clinical Research Organizations
  4. 5.1.3 Academic Institutes
  5. 5.1.4 Specialty Diagnostic Centers
  6. 5.1.5 Others
  7. 5.2 Global Laboratory-Developed Testing Service Sales Value by Application
  8. 5.2.1 Global Laboratory-Developed Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Laboratory-Developed Testing Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Laboratory-Developed Testing Service Sales Value Share by Application (2021-2032)
6 Laboratory-Developed Testing Service Regional Value Analysis
  1. 6.1 Global Laboratory-Developed Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Laboratory-Developed Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Laboratory-Developed Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Laboratory-Developed Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Laboratory-Developed Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Laboratory-Developed Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Laboratory-Developed Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Laboratory-Developed Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Laboratory-Developed Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
7 Laboratory-Developed Testing Service Country-level Value Analysis
  1. 7.1 Global Laboratory-Developed Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Laboratory-Developed Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Laboratory-Developed Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Laboratory-Developed Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quest Diagnostics
  2. 8.1.1 Quest Diagnostics Company Information
  3. 8.1.2 Quest Diagnostics Business Overview
  4. 8.1.3 Quest Diagnostics Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quest Diagnostics Laboratory-Developed Testing Service Product Portfolio
  6. 8.1.5 Quest Diagnostics Recent Developments
  7. 8.2 Thermo Fisher
  8. 8.2.1 Thermo Fisher Company Information
  9. 8.2.2 Thermo Fisher Business Overview
  10. 8.2.3 Thermo Fisher Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Laboratory-Developed Testing Service Product Portfolio
  12. 8.2.5 Thermo Fisher Recent Developments
  13. 8.3 Waters Corporation
  14. 8.3.1 Waters Corporation Company Information
  15. 8.3.2 Waters Corporation Business Overview
  16. 8.3.3 Waters Corporation Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Waters Corporation Laboratory-Developed Testing Service Product Portfolio
  18. 8.3.5 Waters Corporation Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Laboratory-Developed Testing Service Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Illumina
  26. 8.5.1 Illumina Company Information
  27. 8.5.2 Illumina Business Overview
  28. 8.5.3 Illumina Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Illumina Laboratory-Developed Testing Service Product Portfolio
  30. 8.5.5 Illumina Recent Developments
  31. 8.6 Qiagen
  32. 8.6.1 Qiagen Company Information
  33. 8.6.2 Qiagen Business Overview
  34. 8.6.3 Qiagen Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qiagen Laboratory-Developed Testing Service Product Portfolio
  36. 8.6.5 Qiagen Recent Developments
  37. 8.7 Eurofins
  38. 8.7.1 Eurofins Company Information
  39. 8.7.2 Eurofins Business Overview
  40. 8.7.3 Eurofins Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eurofins Laboratory-Developed Testing Service Product Portfolio
  42. 8.7.5 Eurofins Recent Developments
  43. 8.8 Guardant Health
  44. 8.8.1 Guardant Health Company Information
  45. 8.8.2 Guardant Health Business Overview
  46. 8.8.3 Guardant Health Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guardant Health Laboratory-Developed Testing Service Product Portfolio
  48. 8.8.5 Guardant Health Recent Developments
  49. 8.9 Adaptive Biotechnologies
  50. 8.9.1 Adaptive Biotechnologies Company Information
  51. 8.9.2 Adaptive Biotechnologies Business Overview
  52. 8.9.3 Adaptive Biotechnologies Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Adaptive Biotechnologies Laboratory-Developed Testing Service Product Portfolio
  54. 8.9.5 Adaptive Biotechnologies Recent Developments
  55. 8.10 Biodesix
  56. 8.10.1 Biodesix Company Information
  57. 8.10.2 Biodesix Business Overview
  58. 8.10.3 Biodesix Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biodesix Laboratory-Developed Testing Service Product Portfolio
  60. 8.10.5 Biodesix Recent Developments
  61. 8.11 Berry Oncology
  62. 8.11.1 Berry Oncology Company Information
  63. 8.11.2 Berry Oncology Business Overview
  64. 8.11.3 Berry Oncology Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Berry Oncology Laboratory-Developed Testing Service Product Portfolio
  66. 8.11.5 Berry Oncology Recent Developments
  67. 8.12 Genetron Health
  68. 8.12.1 Genetron Health Company Information
  69. 8.12.2 Genetron Health Business Overview
  70. 8.12.3 Genetron Health Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genetron Health Laboratory-Developed Testing Service Product Portfolio
  72. 8.12.5 Genetron Health Recent Developments
  73. 8.13 SRL
  74. 8.13.1 SRL Company Information
  75. 8.13.2 SRL Business Overview
  76. 8.13.3 SRL Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 SRL Laboratory-Developed Testing Service Product Portfolio
  78. 8.13.5 SRL Recent Developments
  79. 8.14 BML
  80. 8.14.1 BML Company Information
  81. 8.14.2 BML Business Overview
  82. 8.14.3 BML Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BML Laboratory-Developed Testing Service Product Portfolio
  84. 8.14.5 BML Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.